SIGA Technologies
SIGA
#8719
Rank
โ‚น21.53 B
Marketcap
โ‚น300.28
Share price
-1.27%
Change (1 day)
-50.79%
Change (1 year)

SIGA Technologies (SIGA) - Total liabilities

Total liabilities on the balance sheet as of March 2026 : โ‚น6.54 Billion

According to SIGA Technologies's latest financial reports the company's total liabilities are โ‚น6.54 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

SIGA Technologies - Total liabilities on balance sheet (from 2001 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31โ‚น1.85 B-24.28%
2024-12-31โ‚น2.44 B-48.86%
2023-12-31โ‚น4.78 B132.52%
2022-12-31โ‚น2.05 B-31.56%
2021-12-31โ‚น3.00 B105.25%
2020-12-31โ‚น1.46 B-79.61%
2019-12-31โ‚น7.18 B2.24%
2018-12-31โ‚น7.02 B-76.47%
2017-12-31โ‚น29.86 B-1.97%
2016-12-31โ‚น30.47 B-2.48%
2015-12-31โ‚น31.24 B21.06%
2014-12-31โ‚น25.80 B136.23%
2013-12-31โ‚น10.92 B157.17%
2012-12-31โ‚น4.24 B61.89%
2011-12-31โ‚น2.62 B291.41%
2010-12-31โ‚น0.67 B-22.98%
2009-12-31โ‚น0.87 B150.08%
2008-12-31โ‚น0.34 B65.48%
2007-12-31โ‚น0.21 B-29.59%
2006-12-31โ‚น0.29 B131.02%
2005-12-31โ‚น0.12 B92.5%
2004-12-31โ‚น67.18 M169.16%
2003-12-31โ‚น24.96 M-20.76%
2002-12-31โ‚น31.5 M-2%
2001-12-31โ‚น32.14 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Sarepta Therapeutics
SRPT
โ‚น161.61 B 2,370.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
โ‚น114.69 B 1,652.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
โ‚น5.31 B-18.80%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
โ‚น0.10 B-98.43%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
โ‚น98.37 B 1,403.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚น76.98 B 1,076.54%๐Ÿ‡บ๐Ÿ‡ธ USA